Relationships between interleukin-12B and interleukin-10 gene polymorphisms and hepatitis C in Chinese Han hemodialysis patients

References

• Fabrizi F, Messa P, Martin P. Impact of hemodialysis therapy on hepatitis C virus infection: A deeper insight. Int J Artif Organs. 2009;32: 1–11
   PubMed Web of Science ®Google Scholar
• Sun J, Yu R, Zhu B, Wu J, Larsen S, Zhao W. Hepatitis C infection and related factors in hemodialysis patients in China: Systematic review and meta-analysis. Ren Fail. 2009;31:610–620
   PubMed Web of Science ®Google Scholar
• Stojanovic M, Stojanovic D, Stefanovic V. The impact of malnutrition on mortality in patients on maintenance hemodialysis in Serbia. Artif Organs. 2008;32:398–405
   PubMedGoogle Scholar
• Di Napoli A, Pezzotti P, Di Lallo D, et al. Epidemiology of hepatitis C virus among long-term dialysis patients: A 9-year study in an Italian region. Am J Kidney Dis. 2006;48:629–637
   PubMed Web of Science ®Google Scholar
• Levrero M. Viral hepatitis and liver cancer: The case of hepatitis C. Oncogene. 2006;25:3834–3847
   PubMed Web of Science ®Google Scholar
• Prezzi C, Cascaiaro MA, Francavilla V, Schiafella E, Finocchi L, Chircu LV. Virus specific CD8(+) T cells with type 1 and type 2 cytokines profile are relate to different disease activity in chronic hepatitis C virus infection. Eur J Immunol. 2001;31: 894–906
   PubMedGoogle Scholar
• Yin LM, Zhu WF, Wei L, et al. Association of interleukin-12 p40 gene 3′-untranslated region polymorphism and outcome of HCV infection. World J Gastroenterol. 2004;10: 2330–2333
   PubMedGoogle Scholar
• Turner DM, Williams DM, Sankaran D, et al. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet. 1997;24: 1–8
   PubMedGoogle Scholar
• Buckham TA, McKnight AJ, Benevente D, et al. Evaluation of five interleukin genes for association with end-stage renal disease in white Europeans. Am J Nephrol. 2010;32: 103–108
   PubMed Web of Science ®Google Scholar
• Tsai SL, Liaw YF, Chen MH, et al. Detection of type 2-like T-Helper cells in hepatitis C virus infection: Implications for hepatitis C virus chronicity. Hepatology. 1997;25: 449–458
   PubMed Web of Science ®Google Scholar
• Chuang JY, Yang SS, Lu YT, et al. IL-10 promoter gene polymorphisms and sustained response to combination therapy in Taiwanese chronic hepatitis C patients. Dig Liver Dis. 2009;41: 424–430
   PubMedGoogle Scholar
• Morgan TR, Lambrecht RW, Bonkovsky HL, et al. DNA polymorphisms and response to treatment in patients with chronic hepatitis C: Results from the HALT-C trial. J Hepatol. 2008;49: 548–556
   PubMedGoogle Scholar
• Huang D, Cancilla MR, Morahan G. Complete primary structure, chromosomal localisation, and definition of polymorphisms of the gene encoding the human interleukin-12 p40 subunit. Genes Immun. 2000;1: 515–520
   PubMed Web of Science ®Google Scholar
• Nieters A, Yuan JM, Sun CL, et al. Effect of cytokine genotypes on the hepatitis B virus-hepatocellular carcinoma association. Cancer. 2005;103: 740–748
   PubMed Web of Science ®Google Scholar
• Randolph AG, Lange C, Silverman EK, et al. The IL-12B gene is associated with asthma. Am J Hum Genet. 2004;75: 709–715
   PubMed Web of Science ®Google Scholar
• Wang C, Zhang X, Zhu B, et al. The relationships between TNF-α, IL-12B and IL-10 gene polymorphisms and hepatitis B in Han Chinese hemodialysis patients. Nephrology (Carlton). 2012;17: 167–174
   PubMedGoogle Scholar
• Xiaoli Z, Dalan H, Bei Z, et al. Tumor necrosis factor-α promoter gene polymorphisms are not associated with Hepatitis C virus infection in Chinese hemodialysis patients. Ren Fail. 2011;33: 593–599
   PubMedGoogle Scholar
• Thimme R, Bukh J, Spangenberg HC, et al. Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease. Proc Natl Acad Sci USA. 2002;99: 15661–15668
   PubMed Web of Science ®Google Scholar
• Biron CA. Cytokines in the generation of immune responses to, and resolution of virus infection. Curr Opin Immunol. 1994;6:530–538
   PubMed Web of Science ®Google Scholar
• Peters M. Actions of cytokines on the immune response and viral interactions: An overview. Hepatology. 1996;23:909–916
   PubMed Web of Science ®Google Scholar
• Chang KM, Thimme R, Melpolder JJ, et al. Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection. Hepatology. 2001;33:267–276
   PubMed Web of Science ®Google Scholar
• Hegazy D, Thurairajah P, Metzner M, et al. Interleukin 12B gene polymorphism and apparent resistance to hepatitis C virus infection. Clin Exp Immunol. 2008;152:538–541
   PubMedGoogle Scholar
• Mueller T, Mas-Marques A, Sarrazin C, et al. Influence of interleukin 12B (IL-12B) polymorphisms on spontaneous and treatment-induced recovery from hepatitis C virus infection. J Hepatol. 2004;41:652–658
   PubMedGoogle Scholar
• Bouzgarrou N, Hassen E, Farhat K, et al. Combined analysis of interferon-γ and interleukin-10 gene polymorphisms and chronic hepatitis C severity. Hum Immunol. 2009;70:230–236
   PubMed Web of Science ®Google Scholar
• Díaz-Valdés N, Manterola L, Belsúe V, et al. Improved dendritic cell-based immunization against hepatitis C virus using peptide inhibitors of interleukin 10. Hepatology. 2010;53:23–31
   PubMedGoogle Scholar
• Brooks DG, Trifilo MJ, Edelmann KH, et al. Interleukin-10 determines viral clearance or persistence in vivo. Nat Med. 2006;12:1301–1309
   PubMed Web of Science ®Google Scholar
• Mangia A, Santoro R, Piattelli M, et al. IL-10 haplotypes as possible predictors of spontaneous clearance of HCV infection. Cytokine. 2004;25:103–109
   PubMed Web of Science ®Google Scholar